David B. T. Cox
Molecular Biology · 2013–2017
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 205 citations into it; #8,143 of 17,773 by trust here, #807 by citations
- Ecology — 36 citations into it
Whom David B. T. Cox trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Rodolphe Barrangou
- Bernd Zetsche
- G. Gasiunas
- P. Hsu
- Jonathan Gootenberg
- Omar Abudayyeh
- Eric S. Lander
- Adam J. Bogdanove
- Philippe Horvath
- Martin Jinek
Who trusts David B. T. Cox overall
- Piotr S. Kowalski
- Jennifer A. Doudna
- Hui Yang
- Thomas J. Cradick
- P. Hsu
- Arnab Rudra
- Christopher A. Lino
- Rodolphe Barrangou
- Hongyi Li
- Joy Y. Wang
Papers from David B. T. Cox's perspective
Ordered by how strongly the researchers David B. T. Cox trusts endorse each paper. Same corpus, a different order for every researcher.
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes (Science)
- CRISPR/Cas, the Immune System of Bacteria and Archaea (Science)
- Discovery and functional characterization of diverse Class 2 CRISPR-Cas systems (Molecules and Cells)
- Evolution and classification of the CRISPR-Cas systems (Nature Reviews Microbiology)
- CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. (Annual Review of Genetics)
- Mechanisms of gene silencing by double-stranded RNA (Nature)
- CRISPR-Cas systems for genome editing, regulation and targeting (Nature Biotechnology)
- RepSeq – A database of amino acid repeats present in lower eukaryotic pathogens (BMC Bioinformatics)
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems (Science)
- Tau-mediated neurodegeneration in Alzheimer's disease and related disorders (Nature Reviews Neuroscience)
Their papers
- Multiplex Genome Engineering Using CRISPR/Cas Systems (2013) — 14,644 citations
- CRISPR-assisted editing of bacterial genomes (2013) — 1,843 citations
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector (2016) — 2,074 citations
- Diversity and evolution of class 2 CRISPR–Cas systems (2017) — 927 citations
- Therapeutic Genome Editing: Prospects and Challenges (2015) — 1,224 citations
- RNA targeting with CRISPR-Cas13a (2017) — 1,762 citations
- RNA Editing with CRISPR-Cas13 (2017) — 1,587 citations
- Engineered Cpf1 variants with altered PAM specificities increase genome targeting range (2017) — 397 citations
- rNA-guided editing of bacterial genomes using crisPr-cas systems (2016)